Sumitomo Pharma America develops and sells prescription medicines for patients with cancer, bladder conditions, women's health disorders and other serious illnesses. Its portfolio combines established treatments with research into diseases that have limited treatment options. The business carries medicines from scientific development and clinical studies through manufacturing and commercialization, with approved products prescribed by healthcare professionals. It operates as the consolidated U.S. pharmaceutical business within Japan's Sumitomo Pharma group. The company traces its roots to 1984, took its combined form in 2023 and is headquartered in Marlborough, Massachusetts.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Marlborough, MA
Founded
1984
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?